| Financial Year |
March 31 2023 |
| Monetary Funds |
269,474,766.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
59,042,241.76 |
| Accounts Receivable |
416,392,504.28 |
| Advances to Suppliers |
44,420,536.24 |
| Other Receivables |
3,708,769.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
658,732,028.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
63,995,392.31 |
| Total Current Assets |
1,681,927,101.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
80,475,252.14 |
| Investment Properties |
1,130,403.65 |
| Fixed Assetes |
1,689,638,554.84 |
| Under-construction Projects |
707,109,941.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
201,629,034.95 |
| R&D expenses |
-- |
| Goodwill |
203,179,912.69 |
| Long-Term Deferred and Prepaid Expenses |
18,048,581.78 |
| Deferred Income Tax Assets |
110,295,926.15 |
| Other Non-Current Assets |
147,428,450.79 |
| Sub-Total of Non-Current Assets |
3,185,757,707.14 |
| Total Assets |
4,867,684,808.19 |
| Short-Term Loans |
233,692,853.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
236,841,330.87 |
| Accounts Payable |
304,620,543.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,729,836.73 |
| Taxes Payable |
25,774,611.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
146,829,732.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
389,214,775.97 |
| Other Current Liabilities |
27,424,389.78 |
| Sub-Total of Current Liabilities |
1,386,859,752.03 |
| Long-term Loans |
563,142,971.44 |
| Bonds Payable |
413,392,337.51 |
| Long-Term Accounts Payable |
79,720,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
122,229,448.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,323,681,324.30 |
| Total Liabilities |
2,710,541,076.33 |
| Paid-In Capital(Or Share Stock) |
393,753,724.00 |
| Capital Surplus |
298,484,879.40 |
| Surplus Reserve |
91,387,728.79 |
| LESS:Treasury Stock |
19,053,225.00 |
| Undistributed Profits |
1,300,667,159.20 |
| Minority Stockholder's Interest |
844,566.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,156,299,165.53 |
| Owner's Equity（Stockholder's Equity） |
2,157,143,731.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,867,684,808.19 |
